Publication | Closed Access

International multicenter randomized, placebo-controlled phase III clinical trial of β-d-mannuronic acid in rheumatoid arthritis patients

Rheumatoid DisorderRheumatologyAutoimmune DiseaseMedicineRheumatic DiseasesImmunologyClinical TrialsOsteoarthritisβ-D-mannuronic AcidAutoimmunityInflammatory Rheumatic DiseaseRheumatoid Arthritis PatientsInternational MulticenterPharmacologyInflammatory ArthritisRheumatoid Arthritis